Significant Ownership of ELI LILLY & Co

Signature - Title: /s/ Christopher Anderson - Christopher Anderson, Vice President, Leader of Corporate Securities and Assistant Corporate Secretary
Location: Indianapolis, IN
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by ELI LILLY & Co.

Notify me when ELI LILLY & Co files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of ELI LILLY & Co

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
AKTSQ	Aktis Oncology, Inc.	Common Stock, $0.0001 par value per share	12%	$63,441		6,344,114		Eli Lilly and Company	12 Jan 2026
	Immunocore Holdings plc	Ordinary Shares	0%			0		ELI LILLY & Co	30 Sep 2025

Schedules 13D/G Reported by ELI LILLY & Co:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Filing Date

* An asterisk sign (*) next to the price indicates that the price is likely invalid.